Benchmarking the Pharmaceutical Market by Drug Delivery to 2014

Drug delivery can play an important role at all stages of a drug's lifecycle and has become an ever present feature in the business model of the leading pharmaceutical companies. Using the PharmaVitae Explorer database, the report provides an in depth sales analysis of the specific routes of administration driving the pharmaceutical market out to 2014.

The oral and injectable segments are the dominant routes of administration in the prescription pharmaceutical market, accounting for more than 80% of combined sales in 2008.

Injectables will see the biggest increase in annual sales at $49 billion over 200814. In contrast, oral drugs will collectively decline by $10.9 billion over the same period.

Slow-growth therapy areas are generally entrenched in oral medications. This dynamic is mirrored by the fast-growth therapy areas, where novel injectable drugs will primarily drive growth.

Read more...

Comments

Add New Search RSS

Write comment
Name:
Email:	do not notifynotify
Website:
Title:
	Please input the anti-spam code that you can read in the image.

Powered by !JoomlaComment 3.26

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

• Drug Delivery Partnership (18/06/2012)
• Polymers (27/12/2010)
• Formulation Technologies for Drug Delivery (25/08/2009)

• HIV/AIDS (26/04/2010)
• Global Diagnostic ECG Market (15/04/2010)
• IVD Market in BRIC Countries (15/04/2010)

• Pharmaceutical Key Trends 2010 (06/04/2010)
• Infant Care (06/04/2010)
• Osteoarthritis (16/02/2010)
• Medical Imaging (15/02/2010)
• Ultrasound Systems Market (15/02/2010)
• Global Hip And Knee Implants (15/02/2010)
• Remote Patient Monitoring (15/02/2010)
• Europe Orthopedic Biomaterials (15/02/2010)
• Cardiac Assist Devices (15/02/2010)

---